Clover Leaf Capital Corp.
NASDAQ:CLOE
12 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.446 | 0.451 | 0.218 | 0.468 | 0.71 | 0.19 | 1.291 | 0.385 | 0.337 | 0.316 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.446 | -0.451 | -0.218 | -0.468 | -0.71 | -0.19 | -1.291 | -0.385 | -0.337 | -0.316 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.316 | 0 | 0 | 0.316 | 0 | 0.331 | 0.007 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.446 | 0.451 | 0.367 | 0.468 | 0.71 | 0.19 | -0.316 | 0.385 | 0.337 | 0.316 | 0.514 | 0.331 | 0.007 | 0.001 |
| Other Expenses
| 0 | 0 | -0.19 | 0 | 0 | 0.19 | 0.57 | 0.385 | 0.337 | 0.342 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.446 | 0.451 | 0.367 | 0.468 | 0.71 | 0.19 | 0.254 | 0.385 | 0.337 | 0.316 | 0.514 | 0.331 | 0.007 | 0.001 |
| Operating Income
| -0.446 | -0.451 | -0.367 | -0.468 | -0.71 | -0.19 | -0.254 | -0.385 | -0.337 | -0.316 | -0.514 | -0.331 | -0.007 | -0.001 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.123 | 0.134 | 0.152 | 0.164 | 0.222 | 0.199 | 0.315 | 0.608 | 0.219 | 0.395 | 0.006 | 0.012 | 0 | 0 |
| Income Before Tax
| -0.324 | -0.316 | -0.216 | -0.304 | -0.488 | 0.009 | 0.062 | 0.223 | -0.118 | 0.078 | -0.507 | -0.319 | -0.007 | -0.001 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.027 | 0.027 | 0.03 | -0.078 | 0.047 | 0.042 | 0.052 | 0.129 | 0.005 | -0.448 | -0.684 | -0.331 | -0.007 | 0 |
| Net Income
| -0.35 | -0.343 | -0.246 | -0.382 | -0.535 | -0.032 | 0.01 | 0.094 | -0.122 | 0.526 | -0.507 | -0.319 | -0.007 | -0.001 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.066 | -0.064 | -0.045 | -0.068 | -0.091 | -0.006 | 0.001 | 0.005 | -0.007 | 0.029 | -0.028 | -0.022 | -0 | -0 |
| EPS Diluted
| -0.066 | -0.064 | -0.045 | -0.068 | -0.091 | -0.006 | 0.001 | 0.005 | -0.007 | 0.029 | -0.028 | -0.022 | -0 | -0 |
| EBITDA
| -0.446 | -0.451 | -0.367 | -0.468 | -0.71 | -0.19 | -0.254 | -0.385 | -0.337 | -0.658 | -0.514 | -0.331 | -0.007 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |